Bioxyne Unit Fulfills Two Purchase Orders for MDMA Capsules in Australia

MT Newswires Live

Nov 11, 2025

Bioxyne (ASX:BXN), through its Breathe Life Sciences subsidiary, fulfilled two standing purchase orders for the supply of BLSMD40 Good Manufacturing Practice-Manufactured MDMA capsules, according to a Tuesday filing with the Australian bourse.

BLSMD40 is an investigational medicine designed to treat post-traumatic stress disorder supplied through Australia's Authorized Prescriber pathway for MDMA-assisted therapy, the filing said.

The capsules are supplied for clinical trials in Victoria and authorized prescribers delivering psychedelic therapy-assisted services in Queensland, per the filing.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2582538335"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2582538335\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2582538335?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-11 11:09","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2582538335","market":"sh","top_or_hot":-1,"title":"Bioxyne Unit Fulfills Two Purchase Orders for MDMA Capsules in Australia","media":"MT Newswires Live","content":"<html><body><p> Bioxyne (ASX:BXN), through its Breathe Life Sciences subsidiary, fulfilled two standing purchase orders for the supply of BLSMD40 Good Manufacturing Practice-Manufactured MDMA capsules, according to a Tuesday filing with the Australian bourse.</p><p>BLSMD40 is an investigational medicine designed to treat post-traumatic stress disorder supplied through Australia's Authorized Prescriber pathway for MDMA-assisted therapy, the filing said.</p><p>The capsules are supplied for clinical trials in <a href=\"https://laohu8.com/S/VCCTF\">Victoria</a> and authorized prescribers delivering psychedelic therapy-assisted services in Queensland, per the filing.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bioxyne Unit Fulfills Two Purchase Orders for MDMA Capsules in Australia</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBioxyne Unit Fulfills Two Purchase Orders for MDMA Capsules in Australia\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-11-11 11:09</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Bioxyne (ASX:BXN), through its Breathe Life Sciences subsidiary, fulfilled two standing purchase orders for the supply of BLSMD40 Good Manufacturing Practice-Manufactured MDMA capsules, according to a Tuesday filing with the Australian bourse.</p><p>BLSMD40 is an investigational medicine designed to treat post-traumatic stress disorder supplied through Australia's Authorized Prescriber pathway for MDMA-assisted therapy, the filing said.</p><p>The capsules are supplied for clinical trials in <a href=\"https://laohu8.com/S/VCCTF\">Victoria</a> and authorized prescribers delivering psychedelic therapy-assisted services in Queensland, per the filing.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7508","symbol_name":"医药生物股","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2582538335","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2582538335","pubTimestamp":1762830549,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Bioxyne , through its Breathe Life Sciences subsidiary, fulfilled two standing purchase orders for the supply of BLSMD40 Good Manufacturing Practice-Manufactured MDMA capsules, according to a Tuesday filing with the Australian bourse.BLSMD40 is an investigational medicine designed to treat post-traumatic stress disorder supplied through Australia's Authorized Prescriber pathway for MDMA-assisted therapy, the filing said.The capsules are supplied for clinical trials in Victoria and authorized prescribers delivering psychedelic therapy-assisted services in Queensland, per the filing.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7508":"医药生物股","BK7111":"个人用品","XJO.AU":"标普/澳交所 200指数","XAO.AU":"标普/澳交所 普通股指数","BXN.AU":"BIOXYNE LTD","XKO.AU":"标普/澳交所 300指数"},"translate_title":"Bioxyne部门在澳大利亚完成了两份MDMA胶囊采购订单","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"XJO.AU":1.5,"XAO.AU":1.5,"XKO.AU":1.5,"BXN.AU":1},"content_text":"Bioxyne (ASX:BXN), through its Breathe Life Sciences subsidiary, fulfilled two standing purchase orders for the supply of BLSMD40 Good Manufacturing Practice-Manufactured MDMA capsules, according to a Tuesday filing with the Australian bourse.BLSMD40 is an investigational medicine designed to treat post-traumatic stress disorder supplied through Australia's Authorized Prescriber pathway for MDMA-assisted therapy, the filing said.The capsules are supplied for clinical trials in Victoria and authorized prescribers delivering psychedelic therapy-assisted services in Queensland, per the filing.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}